Abstract
We tested the hypothesis that D-arginine (D-Arg), which is not a substrate for nitric oxide synthase but scavenges reactive oxygen in vitro, is protective in vivo. Rats were made hypertensive by administering angiotensin II (Ang II) (0.7mg kg(-1) per day) for 7 days (Ang II group). Two other groups additionally received either 3 mmol D-Arg (Ang II + D-Arg group) or vitamin C (1g) (Ang II + Vit C group) per day. Sham-operated animals served as controls (n = 6-9). Systolic blood pressure was monitored daily and cardiovascular function determined ex vivo at 7 days. Ang II raised systolic blood pressure to 184mmHg, the increase was slightly attenuated by D-Arg treatment (-17mmHg; P < 0.05 versus Ang II alone) and prevented by Vit C. Acetylcholine-induced coronary relaxation was impaired in the Ang II group (P < 0.05 versus sham), the impairment was no different in the Ang II + D-Arg group, but prevented by Vit C. Likewise, Vit C but not D-Arg ameliorated reperfusion endothelium-dependent relaxation. However, in aortic rings D-Arg slightly improved acetylcholine relaxation (P < 0.05). Oxidative stress load estimated in plasma with thiobarbituric acid reactive substance was higher in the Ang II than the sham group, Vit C abolished th...Continue Reading
References
Oct 1, 1989·Circulation·L H Opie
Jun 30, 1988·Biochemical and Biophysical Research Communications·R M PalmerS Moncada
Jun 1, 1994·Circulation Research·K K GriendlingR W Alexander
Jun 1, 1993·Journal of Hypertension·K HishikawaT Saruta
Apr 15, 1996·The Journal of Clinical Investigation·S RajagopalanD G Harrison
Apr 15, 1996·The Journal of Clinical Investigation·P ClarksonJ E Deanfield
Mar 1, 1996·Diabetes Care·D GiuglianoG Paolisso
Oct 1, 1995·Atherosclerosis·R H BögerJ C Frölich
Mar 21, 1997·Atherosclerosis·M R AdamsD S Celermajer
May 8, 1997·Biochemical and Biophysical Research Communications·T C WascherW F Graier
Sep 23, 1997·Journal of Molecular and Cellular Cardiology·F Brunner
Nov 10, 1998·Clinical and Experimental Pharmacology & Physiology·G HaklarA S Yalçin
May 4, 2000·Life Sciences·R P BrandesA Mügge
Jun 28, 2000·Cardiovascular Research·F BrunnerT C Wascher
Jul 25, 2000·Hypertension·N D VaziriB Rad
Feb 13, 2001·Clinical Biochemistry·Y L HongM L Hu
Feb 13, 2001·Atherosclerosis·G GoumasP Toutouzas
Sep 22, 2001·Hypertension·X ChenE L Schiffrin
Sep 22, 2001·Hypertension·M C OrtizL A Juncos
Dec 26, 2001·Hypertension·G ZalbaJ Díez
Jan 24, 2002·The Journal of Pharmacology and Experimental Therapeutics·Friedrich BrunnerStephen Haleen
Feb 28, 2002·British Journal of Pharmacology·K de SaramP J Chowienczyk
Mar 9, 2002·Circulation Research·Hanke MollnauThomas Münzel
Mar 29, 2002·Naunyn-Schmiedeberg's Archives of Pharmacology·Astrid SuessenbacherFriedrich Brunner
Apr 19, 2002·Molecular Pharmacology·Achim LassFriedrich Brunner
Oct 17, 2002·Nitric Oxide : Biology and Chemistry·Huige LiUlrich Förstermann
Dec 17, 2002·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·H TapieroK D Tew
Citations
May 11, 2012·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Stephan C SchäferLucia Mazzolai
Jun 16, 2005·Current Opinion in Cardiology·Islam Bolad, Patrice Delafontaine
Aug 21, 2007·Toxicology·Shuichi HaraTakahiko Endo
Aug 4, 2006·Journal of Medicinal Chemistry·Daniela MelisiLucio Annunziato